Medical Research
(H30)
IRS Verified
DX Registered
990 on File
OVERRUN OVARIAN CANCER FOUNDATION INC
Financial strength (30%)
53/100
Reliability (20%)
50/100
Effectiveness (25%)
43/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$110K
Total Revenue
$106K
Total Expenses
$52K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
29.1%
Fundraising Efficiency
N/A
Operating Reserve
5.91x
Liability-to-Asset
N/A
Revenue Diversification
100.0%
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
29.1% | 84.6% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.9 mo | 11.7 mo |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 92.2% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
3.2% | 3.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
1.5% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
3.5% | -1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $110K | $106K | $52K | 29.1% | — |
| 2024 | $106K | $104K | $44K | 27.2% | — |
| 2023 | $91K | $105K | $42K | 27.6% | — |
| 2022 | $108K | $107K | $56K | 29.7% | — |
| 2021 | $164K | $76K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.